Скачайте изображение (превью) выбрав качество

320x180 480x360 640x480 1280x720

Chair, Prof Vijay Kunadian (Newcastle upon Tyne Hospitals NHS Trust, UK) joined by Prof Raj Kharbanda (John Radcliffe Hospital, Oxford, UK), lead researcher of BHF PROTECT-TAVI trial, and Dr Richard J Jabbour (University Hospital Southampton NHS FT, UK) to discuss the use of embolic protection devices in 2023.

This insightful discussion covers various aspects of the topic of embolic protection, including the incidence of stroke in TAVI patients, safety and efficacy data from the latest trials and insights from the BHF PROTECT-TAVI all-comers trial.

1:24: What is the unmet need in the management TAVI patients?
4:46: Review of the latest registry studies and the randomized clinical trial.
8:17: What are the different devices available?
9:47: Tips and tricks of implanting embolic protection devices.
13:18: BHF PROTECT-TAVI all-comers trial
18:00: Practicalities of running the BHF Protect TAVI trial
23:00: Session summary by Dr Kunadian

Recorded on-site at BCIS ACI 2023, London.

Visit Radcliffe Cardiology:

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.

Like us on Facebook:
Follow us on Twitter:

Чтобы скачать видео "Use of Cerebral Embolic Protection in 2023" передвинте ползунок вправо